-
General Office of the State Council Issued the Key Tasks for Deepening the Reform of the Pharmaceutical and Healthcare System in 2019
2019-07-18
Recently, the General Office of the State Council issued the Key Tasks for Deepening the Reform of the Pharmaceutical and Healthcare System in 2019.
-
2019 China Cancer Immunotherapy Workshop Successfully Held
2019-07-18
2019 China Cancer Immunotherapy Workshop was successfully held on June 29- 30, 2019 in Tianjin, China.
-
NMPA Issued the Announcement on Issues Concerning the Import of Reference Drugs for Clinical Research of Biosimilar Drugs
2019-07-06
On November 30, 2018, NMPA issued the Announcement on Issues Pertaining to the One-off Import of Reference Drugs for Biologicals in Clinical Trials (Announcement No. 94 of 2018).
-
SAMR Issued the Measures for the Administration of Imported Medicinal Materials
2019-07-06
The State Administration for Market Regulation (SAMR) issued the revised Measures for the Administration of Imported Medicinal Materials on May 16,2019.
-
The 2018 Drug Review Annual Report released
2019-07-06
The 2018 Drug Review Annual Report was released on July 1,2019.
-
CDE Released the List of the Second Batch of Overseas New Drugs Urgently Needed in Clinical Settings
2019-07-06
On May 29, 2019, NMPA Center for Drug Evaluation issued the Notice on the Issuance of the List of the Second Batch of Overseas New Drugs Urgently Needed in Clinical Settings.
